CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.
Fischbach F, Richter J, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, Kuhle J, Badbaran A, Rathje K, Gagelmann N, Borie D, Seibel J, Ayuk F, Friese MA, Heesen C, Kröger N.
Fischbach F, et al.
Med. 2024 Mar 22:S2666-6340(24)00114-4. doi: 10.1016/j.medj.2024.03.002. Online ahead of print.
Med. 2024.
PMID: 38554710
Free article.